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Abstract Septins are evolutionary conserved cytoskeletal
GTPases forming heteropolymer complexes involved in cytoki-
nesis and other cellular processes. CDCrel-1 (cell division cycle
related-1) is a recently cloned and characterized human septin
which is highly expressed in non-dividing cells, such as neurons.
Using a yeast two-hybrid system we demonstrate that CDCrel-1
partners with another uncharacterized human septin, KIAA0202.
The interaction of CDCrel-1 and KIAA0202 was confirmed in
the human leukemia cell line K-562 using pull-down assays with a
KIAA0202^glutathione S-transferase fusion protein and by
immunoprecipitation of the CDCrel-1^KIAA0202 complex with
an anti-KIAA0202 antibody. Expression studies of the two
human septins revealed a concomitant expression of both
proteins in certain cells. / 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Septins are a cytoplasmic family of proteins essential for
cytokinesis in yeast. A plethora of data has documented yeast
mutants and their inability to undergo yeast budding [1^4].
Indeed, it was originally suggested that septin proteins may be
restricted to the mechanisms involved in asymmetric cell divi-
sion and, as such, not relevant for higher eukaryotic organ-
isms [2]. However, a growing appreciation for septin proteins
in higher eukaryotic organisms suggests an involvement in
other, albeit similar, cellular processes [5,6]. Some recently
characterized human septins are highly expressed in cells not
undergoing active cell division, such as neurons [7,8]. In these
cases, septins have been puri¢ed as components of the exo-
cytic cellular machinery [9,10].
Puri¢ed septin complexes from yeast appear as ¢laments
when viewed by transmission electron microscopy and have
the ability to assemble into long ¢lament complexes in vitro
[11]. Puri¢ed complexes of multiple septins have been reported
for yeast, Drosophila and rat, with molecular masses ranging
from 340 to 370 kDa [10^12]. Thus, the possibility of septin^
septin interaction for normal complex assembly may represent
a mechanism whereby cell-speci¢c septin complexes are gen-
erated for a specialized role in a particular cell type.
We report for the ¢rst time the interaction of two human
septins. CDCrel-1 (cell division cycle related-1) associates with
KIAA0202 and both display a similar, yet restricted, gene
expression pattern.
2. Materials and methods
2.1. Yeast two-hybrid method
The Matchmaker yeast two-hybrid-system II was purchased from
Clontech and performed according to the manufacturer’s manual [13].
The yeast two-hybrid plasmid pAS2-1 containing CDCrel-1 (accession
no. U74628, nucleotides 83^2032) was used as the target in pre-trans-
formed fetal brain cDNA- and heart cDNA-libraries made in pACT2.
Three fragments of CDCrel-1 were generated by PCR and cloned
into the vector pAS2-1. The ¢rst fragment (550 bp) covered the ¢rst
two GTP-binding motifs, the second fragment (784 bp) included all
three GTP-binding motifs and the third fragment (723 bp) corre-
sponded to the GTP-motif AKAD and the ‘coiled-coil’ domain. The
constructs of the fragments were cotransformed with KIAA0202 in
the yeast strain PJ69-2A and interaction was demonstrated by Hisþ,
Adeþ and lacZþ transformants.
2.2. Quantitative L-Gal assay
The quantitative L-Gal assay was performed using o-nitrophenyl-L-
D-galactopyranoside as substrate according to the yeast protocol
handbook (Clontech) [13]. Positive controls were performed with
p53 and SV40 large T-antigen. Negative controls were performed by
cotransformation of CDCrel-1 and SV40 large T-antigen as well as by
cotransformation of p53 and KIAA0202.
2.3. Glutathione S-transferase (GST) pull-down
The recombinant GST^KIAA0202 fusion protein (19^2225, acces-
sion nos. AF179995 and D86957, pGEX4T-2, BL21/DE3) was bound
to glutathione Sepharose (Amersham Pharmacia) [14]. Cells of the
human tumor cell line K-562 were collected and lysed with RIPA-
bu¡er (9.1 mM Na2HPO4, 1.7 mM NaH2PO4, 150 mM NaCl, 1%
NP-40, 0.5% Na^desoxycholat, 0.1% SDS, pH 7.4; addition of pro-
teinase inhibitors prior to use). The supernatant was diluted with PBS
bu¡er and applied to the KIAA0202 immobilized on glutathione
Sepharose. Elution was reached by 20 mM reduced glutathione.
CDCrel-1 interacting with the KIAA0202^GST fusion protein was
detected by Western analysis using a monoclonal anti-CDCrel-1 anti-
body. Control pull-down assays with the GST vector lacking the
KIAA0202 insert and with glutathione Sepharose were performed to
exclude an unspeci¢c association.
2.4. Immunoprecipitation
Protein A Sepharose was washed with PBS bu¡er (9.1 mM
Na2HPO4, 1.7 mM NaH2PO4, 150 mM NaCl, pH 7.4). K-562 lysate
was incubated with Protein A Sepharose (1 h at 4‡C) in the presence
of proteinase inhibitors. After centrifugation, the supernatant was
subjected to anti-KIAA0202 antibody bound to Protein A Sepharose
(1 h at 4‡C). The Protein A Sepharose was subsequently washed for
several times with PBS bu¡er. Bound proteins were eluted with lith-
ium dodecyl sulfate (LDS)-sample bu¡er (1.09 M glycerol, 1.41 mM
Tris base, 106 mM Tris^HCl, 73 mM LDS, 0.51 mM EDTA, 0.22 mM
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Serva Blue G250, 0.175 mM phenol red, pH 8.5) for 5 min at 95‡C.
Control experiments were carried out with rabbit serum or without
any antibody.
2.5. Western analysis
Protein medleys of brain and heart were purchased from Clontech
(#7800-1, #7801-1). Human platelets were lysed with RIPA bu¡er.
Proteins were separated by gradient SDS^PAGE (4^12%) after dena-
turation and reduction. After electrophoresis, proteins were trans-
ferred to PVDF membranes to react with the corresponding antibody.
Positive signals were detected using a peroxidase-conjugated A⁄ni-
Pure goat anti-mouse (1:50 000) (Dianova) or peroxidase-conjugated
goat anti-rabbit antibody IgG(H-L) (1:50 000) (Pierce) and the ECL-
system (Amersham Pharmacia).
2.6. RNA isolation and Northern transfer
Total RNA from the human tumor cell line K-562 and from human
platelets was isolated by ultracentrifugation through cesium chloride
cushions. Poly(A)þRNA was prepared from K-562 total RNA by
a⁄nity chromatography using oligo(dT) cellulose columns (Life Tech-
nologies). Gel electrophoretic separation of K-562 poly(A)þRNA and
platelet total RNA was performed through denaturing formaldehyde
gels prepared as described by Lehrach et al. [15]. Then, the RNA was
transferred from the gel onto nitrocellulose by capillary forces. In
addition, mRNA blots were purchased from Clontech containing
mRNA isolated from brain and heart tissues (#7755-1, #7791-1)
(Fig. 4A).
The hybridization probe for CDCrel-1 was a 600 bp 5P-fragment
and the hybridization probe for KIAA0202 was a 590 bp 5P-fragment
[16]. After hybridization, the nitrocellulose ¢lter was washed three
times with 0.3 M sodium chloride/0.03 M sodium citrate/0.1% SDS
(42‡C) and two times with 0.15 M sodium chloride/0.015 M sodium
citrate/0.1% SDS (55‡C). Clontech blots were washed according to the
supplierPs instructions. Then the nitrocellulose or the nylon membrane
was analyzed by autoradiography using Kodak Biomax MR ¢lm. A
¢nal hybridization with a human L-actin or with a glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) cDNA probe con¢rmed the pres-
ence of mRNA on the membrane.
2.7. Antibodies against KIAA0202
The 5P-end of KIAA0202 was cloned into the pET30c vector.
KIAA0202 (amino acids 8^113) was expressed as His-tagged protein
in the Escherichia coli strain BL21/DE3. The recombinant protein was
puri¢ed with a His-bind-resin (Novagen). Polyclonal antibodies were
raised in rabbits (Eurogentec).
3. Results
To identify proteins interacting with human CDCrel-1, we
constructed a recombinant plasmid containing the in-frame
coding sequence for the DNA binding domain (DBD) of
Gal4 and the coding sequence for the residues 83^2032 of
CDCrel-1 (accession no. U74628). A fetal brain cDNA library
expressing fusions of the activation domain (AD) of Gal4 was
screened using a yeast two-hybrid system. Sixteen positive
clones were identi¢ed from a screening of 9.4U108 transform-
ants. Sequence analyses of these clones revealed that 12 clones
were unique and contained the coding sequence for another
human septin, KIAA0202 (accession nos. AF179995 and
D86957). The KIAA0202 cDNA sequence is present in Gen-
Bank but no further characterization of the gene/protein has
been reported.
A second AD library containing cDNA prepared from hu-
man adult heart mRNA was also screened (3.5U109 clones)
and provided similar results with the isolation of more clones
containing KIAA0202 coding sequence. Isolated KIAA0202
cDNA fragments contained unique 5P-ends corresponding to
nucleotides 19, 23, 75, 83, 305, 371, 407 and 662 of GenBank
accession no. D86957. To examine the interaction speci¢city
between the DBD^CDCrel-1 and AD^KIAA0202 fusion pro-
teins, the KIAA0202 recombinant plasmids were cotrans-
formed with other yeast two-hybrid vectors. No positive sig-
nals were generated in the absence of the human CDCrel-1
coding sequence. Quantitative analysis of the L-galactosidase
activity generated in the presence of DBD^CDCrel-1 and
AD^KIAA0202 is shown in Fig. 1 along with control con-
Fig. 1. Quantitative analysis of the L-galactosidase activity generated
in the presence of DBD^CDCrel-1 and AD^KIAA0202 is shown
along with control constructs coding for either the DBD from
c-Myc-p53 or AD from the SV40 large T-antigen. Demonstrated is:
(i) the strong interaction of CDCrel-1 with KIAA0202, (ii) the posi-
tive control c-Myc-p53 with SV40 large T-antigen, (iii) the negative
control CDCrel-1 with SV40 large T-antigen and (iv) the negative
control c-Myc-p53 with KIAA0202.
Fig. 2. GST pull-down assay using a KIAA0202^GST fusion pro-
tein. Coomassie stain of SDS^PAGE (A) and Western analysis (B)
using an anti-CDCrel-1 monoclonal antibody were performed. A
strong signal (B) was observed corresponding to the migration posi-
tion of CDCrel-1 (45 kDa). Lane 1: K-562 lysate; lane 2: K-562 ly-
sate that did not bind to glutathione Sepharose (negative control);
lane 3: K-562 lysate that did not bind to GST^glutathione Sepha-
rose (negative control); lane 4: K-562 lysate that did not bind to
GST^KIAA0202^glutathione Sepharose; lane 5: proteins of K-562
lysate that bind to glutathione Sepharose (negative control); lane 6:
proteins of K-562 that bind to GST^glutathione Sepharose (negative
control); lane 7: proteins of K-562 lysate that bind to GST^
KIAA0202^glutathione Sepharose.
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structs coding for either the DBD from c-Myc-p53 or AD
from the SV40 large T-antigen. The interaction between
CDCrel-1 and KIAA0202 is very strong and comparable to
that of c-Myc-p53 and SV40 large T-antigen.
To verify the interaction observed in the yeast two-hybrid
system, GST pull-down experiments were carried out. We
have previously reported that the human leukemia cell line
K-562 expresses CDCrel-l [17]. Thus, we used K-562 cell ex-
tracts to determine if an interaction occurs between CDCrel-1
and KIAA0202. An expressed GST^KIAA0202 fusion protein
was immobilized on glutathione Sepharose beads and mixed
with a K-562 cell lysate. The bound proteins were eluted and
analyzed by SDS^PAGE and Western blot analysis using an
anti-CDCrel-1 monoclonal antibody (Fig. 2). A strong signal
was observed corresponding to the migration position of
CDCrel-1 (45 kDa). Mixture of a GST fusion protein lacking
the KIAA0202 sequence (KIAA0202 protein) or glutathione
Sepharose with K-562 lysate did not result in the pull-down of
the human CDCrel-1 protein. Additionally, we performed an
immunoprecipitation of the CDCrel-1^KIAA0202 complex
with the anti-KIAA0202 antibody in K-562 lysate. The anti-
body was immobilized on Protein A Sepharose and mixed
with a K-562 cell lysate. The bound proteins were eluted
and analyzed by SDS^PAGE and Western blot analysis using
an anti-CDCrel-1 monoclonal antibody. A protein with the
migration position of CDCrel-1 (45 kDa) could be detected
(Fig. 3). The 45 kDa CDCrel-1 band could not be detected
using rabbit serum or Protein A Sepharose. The results of the
GST pull-down and the immunoprecipitation are thus consis-
tent with those of the yeast two-hybrid experiments and dem-
onstrate an intermolecular association between human
CDCrel-1 and KIAA0202 in cells expressing both proteins.
We previously reported that another septin, human
CDCrel-2, shares a remarkable similarity to the human
CDCrel-1 cDNA and protein sequence [17]. However,
CDCrel-1 and CDCrel-2 are di¡erent in their expression pat-
terns. This observation was most apparent in the analysis of
tumor cell lines in which the expression analysis for CDCrel-1
and CDCrel-2 was examined and no overlap in the expression
pattern was seen. A similar analysis of KIAA0202 mRNA and
CDCrel-1 mRNA was performed in the K-562 tumor cell line,
Fig. 3. Immunoprecipitation of CDCrel-1 from the human leukemia
cell line K-562 by an anti-KIAA0202 polyclonal antibody. Coomas-
sie stain of SDS^PAGE (A) and Western blot analysis (B) using an
anti-CDCrel-1 monoclonal antibody were performed. Lane 1: K-562
lysate; lane 2: K-562 lysate that did not bind to Protein A Sepha-
rose (negative control); lane 3: K-562 lysate that did not bind to
rabbit serum immobilized on Protein A Sepharose (negative con-
trol); lane 4: K-562 lysate that did not bind to anti-KIAA0202 anti-
body immobilized on Protein A Sepharose; lane 5: elution fraction
of proteins (K-562 lysate) that bind to Protein A Sepharose (nega-
tive control); lane 6: elution fraction of proteins (K-562 lysate) that
bind to rabbit serum immobilized on Protein A Sepharose (negative
control); lane 7: elution fraction of proteins (K-562 lysate) that
bind to anti-KIAA0202 antibody immobilized on Protein A Sepha-
rose. The CDCrel-1 protein is marked with an arrow (45 kDa).
Fig. 4. A: Northern analyses for CDCrel-1 (3.5, 2.4 kb) and
KIAA0202 (4.4, 2.8, 2.2 kb) in poly(Aþ)RNA from human brain
(lane 1: cerebellum, lane 2: cerebral cortex), human heart (lane 1:
fetal heart, lane 2: adult heart), total RNA from platelets and poly-
(Aþ)RNA from K-562 (chronic myelogenous leukemia). Shown be-
low is the autoradiograph from a hybridization of the ¢lter with a
human L-actin or G3PDH probe. B: Western analyses of CDCrel-1
and KIAA0202. Lane 1: brain, lane 2: platelets, lane 3: heart.
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brain, heart tissue and platelets (Fig. 4A). The autoradiograph
documents two hybridizing mRNA species of 3.5 and 2.4 kb
for CDCrel-1 [8,17]. We observed a strong correlation be-
tween the presence of the human CDCrel-1 mRNA and the
KIAA0202 mRNA (Fig. 4A). In addition, CDCrel-1 protein
and KIAA0202 protein were detected in brain, heart tissue
and in platelets (Fig. 4B).
As for CDCrel-1 [8] several transcripts of KIAA0202 (4.4,
2.8, 2.2 kb) could be detected in Northern analysis. By screen-
ing three di¡erent cDNA libraries we identi¢ed these tran-
scripts as di¡erent splice variants of KIAA0202.
4. Discussion
The septin family of proteins was originally identi¢ed in
yeast through the analysis of temperature-sensitive mutants
showing impaired cytokinesis and budding [3]. The loss of
yeast septins coincided with a loss of neck ¢laments in bud-
ding yeast. Subsequent studies established that septins con-
tribute to the formation of these ¢lamentous structures and
that multiple septins assemble into a large protein complex
[18]. Indeed, septins and their association with these ¢lamen-
tous structures have led to the hypothesis that septins may
represent a novel class of cytoskeletal ¢laments [19]. More
recently, work has demonstrated that septin homologs extend
well-beyond yeast and are present in a wide variety of eukary-
otic cells [5,20^22]. Again, protein complexes composed of
multiple septin proteins have been puri¢ed from mammalian
cell extracts [23,24]. Intriguingly, mammalian septins can be
puri¢ed with components of the exocytic or t-SNARE com-
plex involved in regulated cellular secretion [9,10]. Thus, for
mammalian cells there is speculation that septins form a scaf-
folding matrix upon which other proteins assemble and per-
form a unique job for a particular cell type [18].
An intriguing aspect of the septin gene family is the re-
stricted expression pattern for individual septin genes. This
leads to the possibility that the septin^septin interaction
may generate cell-speci¢c complexes with a unique function
for a given cell type. In the current study we used one of the
best-characterized human septin genes, CDCrel-1 to probe a
library of cDNAs looking for potential interaction partners.
The results from screening two di¡erent human cDNA libra-
ries illustrate an interaction with the septin KIAA0202. A
cDNA sequence of KIAA0202 is present in GenBank (acces-
sion nos. D86957 and AF179995) but no further character-
ization of this sequence has been reported. Moreover, North-
ern analysis for the KIAA0202 mRNA transcript revealed a
strikingly similar pattern to that observed for the CDCrel-1
mRNA. In addition, the presence of CDCrel-1 protein coin-
cides with the presence of the KIAA0202 protein and further
supports a hypothesis that septin complexes containing di¡er-
ent polypeptides may assemble to accomplish biological pro-
cesses unique to the particular cell type.
Beyond the yeast two-hybrid system, we documented in a
pull-down assay the ability of recombinant GST^KIAA0202
to interact with native CDCrel-1 present in extracts from the
cell line K-562. Furthermore, we showed the interaction of
native KIAA0202 and CDCrel-1 in the extracts from the
cell line K-562 by immunoprecipitation. Quantitative analysis
demonstrated that the interaction between CDCrel-1 and
KIAA0202 is as strong as one of the well-characterized pos-
itive controls for the two-hybrid system; namely, the interac-
tion between SV40 large T-antigen and the p53 AD (Fig. 1).
We attempted to further localize the interaction domain of
CDCrel-1 with KIAA0202 by making deletions within the
coding sequence of CDCrel-1. In all cases, any removal of
CDCrel-1 sequence resulted in lack of interaction with
KIAA0202 (data not shown). Thus, the interaction between
CDCrel-1 and KIAA0202 seems to be dependent upon the
intact protein and what is presumed to be some native folding
of the CDCrel-1 polypeptide.
Our study validates the yeast two-hybrid system as a tool to
identify potential septin interaction partners. Given the pres-
ence of at least eight individual human septin genes, the use of
a yeast two-hybrid system coupled with expression analysis of
individual cell types is useful in de¢ning the constituent poly-
peptides comprising the larger septin complexes within an in-
dividual cell.
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